The role of cGAS-STING pathway in diabetic complications. (a) In DN, the high glucose environment generates large amounts of ROS, which disrupts mitochondrial function and leaks mtDNA to the extracellular compartment, which activates the cGAS-STING pathway and leads to the activation of the downstream NF-κB, JAK-STAT, and NLRP3 inflammatory pathways, resulting in kidney injury. (b) MAFLD belongs to a class of NAFLD caused by excessive FFA accumulation in T2D, MAFLD leads to the development of IR and progression to hepatitis and cirrhosis. In NAFLD, macrophages are able to activate cGAS-STING via EVs and later phosphorylate p62 and TBK1, producing lipotoxicity-induced ubiquitination and large protein inclusions, which are hallmarks of NAFLD, leading to hepatitis and cirrhosis development. (c) AGEs are increased in diabetic myocardium, which can lead to myocardial sclerosis. Oxidative stress is also increased in diabetic myocardium and FFA-associated mitochondrial uncoupling occurs, which all contribute to the development of DC. At the same time, leukocytes such as macrophages begin to activate. At the mechanistic level, db/db mice are fed via HFD, which leads to mtDNA leakage and activation of cGAS-STING as well as the pyroptosis pathway, leading to the development of DC. In contrast, Metrnl was able to inhibit cGAS-STING as well as pyroptosis via ULK1, thereby alleviating DC. (d) In diabetes skin tissues and adipocytes, the high glucose microenvironment will lead to the excessive production of ROS in keratinocytes, destroy mitochondrial function, and lead to the release of mitochondrial DNA into the cytoplasm, thus activating the cGAS-STING pathway, which leads to increased apoptosis, thus inhibiting DWH. Lipotoxicity in adipocytes can also lead to the release of mtDNA, thereby activating the cGAS-STING pathway and leading to obesity type inflammation. DsbA-L can prevent the occurrence of this pathway, thereby inhibiting the aging caused by obesity. STAT1/3 plays two opposite roles in this process. STAT3 can inhibit obesity induced aging, while STAT1 and IFN can promote inflammation caused by cGAS-STING in obesity. In macrophages, JMJD3 causes STING activation and increases M1 polarization, resulting in delayed DWH, which can be inhibited by insulin. PA can also lead to the release of mtDNA from vascular endothelial cells and the activation of cGAS-STING, which can inhibit the HIPPO-YAP classic pathway, thereby inhibiting angiogenesis and slowing down DWH. JMJD3 jumonji domain-containing protein-3, DN Diabetic nephropathy, ROS reactive oxygen species, mtDNA mitochondrial DNA, cGAS cyclic GMP-AMP synthase, cGAMP 2′3′cyclic GMP–AMP, STING stimulator of interferon genes, TBK1 TANK-binding kinase 1, IRF3 interferon regulatory factor 3, T2D type 2 diabetes, FFA free fatty acid, MAFLD metabolic dysfunction-associated fatty liver disease, IR insulin resistance, NAFLD non-alcoholic fatty liver disease, AGEs advanced glycation end products, DC diabetic cardiomyopathy, ULK1 UNC-52-like kinase 1, HFD high-fat diet, ERS endoplasmic reticulum stress, DsbA-L disulfide bond A oxidoreductase-like protein, WAT white adipose tissue, WH wound healing, PA palmitic acid, cGAS-STING cyclic GMP-AMP synthase-stimulator of interferon genes